The polar region consecutive to the HIV fusion peptide participates in membrane fusion

Biochemistry

Volumn 39, Issue 7, 2000, Pages 1826-1833

  Peisajovich, Sergio Gerardo ^a   Epand, Raquel F ^b   Pritsker, Moshe ^a   Shai, Yechiel ^a   Epand, Richard M ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; LIPOSOME;

ARTICLE; BILAYER MEMBRANE; CARBOXY TERMINAL SEQUENCE; FLUORESCENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE FUSION; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE;

AMINO ACID SEQUENCE; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; LIPID BILAYERS; LIPOSOMES; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; PALMITIC ACIDS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL FUSION PROTEINS; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034700998     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi991887i     Document Type: Article

References (41)

1. Chan, D. C., Pass, D., Berger, J. M., and Kim, P. S. (1997) Core structure of gp41 from the HIV envelope glycoprotein, Cell 89, 263-273.
2. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1997) Atomic structure of the ectodomain from HIV-1 gp41, Nature 387, 426-430.
3. Rafalski, M., Lear, D., and DeGrado, W. F. (1990) Phospholipid interaction of synthetic peptides representing the N-terminus of HIV gp41, Biochemistry 29, 7917-7922.
4. Nieva, J. L., Nir, S., Muga, A., Goñi, F. M., and Wilschut, J. (1994) Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage, Biochemistry 33, 3201-3209.
5. Martin, I., Schaal, H., Scheid, A., and Ruysschaert, J.-M. (1996) Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer, J. Virol. 70, 298-304.
6. Mobley, P. W., Waring, A. J., Sherman, M. A., and Gordon, L. M. (1999) Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs. Biochim. Biophys. Acta 1418, 1-18.
7. Pritsker, M., Jones, P., Blumenthal, R., and Shai, Y. (1998) A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion, Proc. Natl. Acad. Sci. U.S.A. 95, 7287-7292.
8. Kliger, Y., Aharoni, A., Rapaport, D., Jones, P., Blumenthal, R., and Shai, Y. (1997) Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study, J. Biol. Chem. 272, 13496-13505.
9. Pereira, F., Goñi, F., and Nieva, J. (1995) Liposome destabilization induced by the HIV-1 fusion peptide. Effect of a single amino acid substitution, FEBS Lett. 362, 243-246.
10. Brasseur, R. (1990) TAMMO: Theoretical analysis of membrane molecular organization, in Molecular description of biological membranes by computer aided conformational analysis (Brasseur, R., Ed.) Vol. 1, pp 203-220, CRC Press, Boca Raton, FL.
11. Brasseur, R., Vandenbranden, M., Cornet, B., Burny, A., and Ruysschaert, J.-M. (1990) Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide at the N-terminus of viral fusion proteins, Biochim. Biophys. Acta 1029, 267-273.
12. 2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes, Biochim. Biophvs. Acta 1145, 124-133.
13. 2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study, J. Virol. 68, 1139-1148.
14. Horth, M., Lambrecht, B., Thiriart, C., Ruysschaert, J.-M., Burny, A., and Brasseur, R. (1991) Theoretical and functional analysis of the SIV fusion peptide, EMBO J. 10, 2747-2755.
15. Schaal, H., Klein, M., Gehrmann, P., Adams, O., and Scheid, A. (1995) Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion, J. Virol. 69, 3308-3314.
16. Epand, R. M. (1998) Lipid polymorphism and protein-lipid interactions, Biochim. Biophys. Acta 1376, 353-368.
17. Colotto, A., Martin, I., Ruysschaert, J.-M., Sen, A., Hui, S. W., and Epand, R. M. (1996) Structural study of the interaction between the SIV fusion peptide and model membranes, Biochemistry 35, 980-989.
18. Colotto, A., and Epand, R. M. (1997) Structural study of the relationship between the rate of membrane fusion and the ability of the fusion peptide of Influenza virus to perturb bilayers, Biochemistry 36, 7644-7651.
19. Killian, J. A., Salemink, I., de Planque, M., Lindblom, G., Koeppe, R. E., II. and Greathouse, D. V. (1996) Induction of non-bilayer structures in diacylphosphatidylcholine model membranes by transmembrane α-helical peptides: Importance of Hydrophobic mismatch and proposed role of tryptophans, Biochemistry 35, 1037-1045.
20. Siegel, D. P., and Epand, R. M. (1997) The mechanism of the lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: Implications for membrane fusion mechanisms, Biophys. J. 73, 3089-3111.
21. Curtain, C., Separovic. F., Nielsen, K., Craik, D., Zhong, Y., and Kirkpatrick, A. (1999) The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids, Eur. Biophys. J. 28, 427-436.
22. Chang, D.-K., Cheng, S.-F., and Trivedi, V. D. (1999) Biophysical characterization of the structure of the amino-terminal region of gp41 of HIV-1, J. Biol. Chem. 274, 5299-5309.
23. Epand, R. F., Macosko, J. C., Russell, C. J., Shin, Y.-K., and Epand, R. M. (1999) The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion, J. Mol. Biol. 286, 489-503.
24. Slepushkin, V. A., Melikyan, G. B., Sidorova, M. S., Chumakov, V. M., Andreev, S. M., Manulyan, R. A., and Karamov, E. V. (1990) Interaction of HIV-1 fusion peptides with artificial lipid membrane, Biochem. Biophys. Res. Commun. 172, 952-957.
25. Merrifield, R. B., Vizioli, L. D., and Boman, H. G. (1982) Synthesis of the antibacterial peptide cecropin A (1-33). Biochemistry 21, 5020-5031.
26. Shai, Y., Bach, D., and Yanovsky, A. (1990) Channel formation properties of synthetic pardaxin and analogues, J. Biol. Chem. 265, 20202-20209.
27. Olson, F., Hunt, C. A., Szoka, F. C., Vail, W. J., and Papahadjopoulos, D. (1979) Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes, Biochim. Biophvs. Acta 557, 9-23.
28. Mayer, L. D., Hope, M. J., and Cullis, P. R. (1986) Vesicles of variable sizes produced by a rapid extrusion procedure, Biochim. Biophys. Acta 858, 161-168.
29. Ames, B. N. (1966) Assay of inorganic phosphate, total phosphate and phosphatases, in Methods in Enzymology (Neufeld, E. F., and Ginsburg, V., Eds.) Vol. VIII, pp 115-118, Academic Press, New York.
30. Sturtevant, J. M. (1987) Biochemical applications of differential scanning calorimetry, Annu. Rev. Phys. Chem. 38, 463-488.
31. 2+-induced fusion and destabilization of liposomes, Biochemistry 24, 3099-3106.
32. Struck, D. K., Hoekstra, D., and Pagano, R. E. (1981) Use of resonance energy transfer to monitor membrane fusion, Biochemistry 20, 4093-4099.
33. Rajarathnam, K., Hochman, J., Schindler, M., and Ferguson, M. S. (1989) Synthesis, location, and lateral mobility of fluorescently labeled ubiquinone 10 in mitochondrial and artificial membranes. Biochemistry 28, 3168-3176.
34. Gazit, E., Miller, I. R., Biggin, P. C., Sansom, M. S. P., and Shai, Y. (1996) Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes, J. Mol. Biol. 258, 860-870.
35. Surewicz, W. K., Manisch, H. H., and Chapman, D. (1993) Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment, Biochemists 32, 389-394.
36. Basañez, G., Goni, F. M., and Alonso, A. (1998) Effect of single chain lipids on phospholipase C-promoted vesicle fusion. A test for the stalk hypothesis of membrane fusion, Biochemists 37, 3901-3908.
37. Melikyan, G. B., Niles, W. D., Peeples, M. E., and Cohen, F. S. (1993) Influenza hemagglutinin-mediated fusion pores containing cells to planar membranes: flickering to final expansion, J. Gen. Physiol. 102, 1131-1149.
38. Pécheur, E. I., Hoekstra, D., Sainte-marie, J., Mourin, L., Bienvenue, A., and Philippot, J. R. (1997) Membrane anchorage brings about fusogenic properties in a short synthetic peptide, Biochemistry 36, 3773-3781.
39. Lohner, K., and Epand, R. M. (1996) Membrane Interactions of Hemolytic and Antibacterial Peptides, Prog. Biophys. Chem. 6, 53-66.
40. Ghosh, J. K., and Shai, Y. (1999) Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion, J. Mol. Biol. 292, 531-546.
41. Jackson, M., and Manisch, H. H. (1995) The use and misuse of FTIR spectroscopy in the determination of protein structure, Crit. Rev. Biochem. Mol. Biol. 30, 95-120.